Mulmit

Inhibitor Therapeutics, Inc.Inhibitor Therapeutics, Inc.

INTI OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2021-12-310-325,395-298,6320
2020-12-310-1,058,987-1,057,929
2019-12-310-2,747,896-2,733,356
2018-12-310-4,564,257-4,550,230
2017-12-310-5,119,031-5,101,165

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-01Black Robe Capital LLC3,200,000
2026-05-05Vasisht Niraj50,000
2026-05-04OSMAN RONALD E50,000
2026-05-04Yanez Michelle50,000
2026-05-04SEARS SAMUEL P JR50,000
2026-05-04ODONNELL FRANCIS E JRChief Executive Officer50,000
2026-05-04Jerman Michael Allen50,000
2025-04-01Vasisht Niraj50,000
2025-04-01Yanez Michelle50,000
2025-04-01SEARS SAMUEL P JR50,000
2025-04-01OSMAN RONALD E50,000
2025-04-01Jerman Michael Allen50,000

8-K events

FiledItems
2026-04-01Regulation FD disclosure · Financial statements and exhibits
2026-04-01Other events · Financial statements and exhibits
2026-02-24Entry into a material agreement · Financial statements and exhibits
2025-10-27Entry into a material agreement · Officer or director change · Financial statements and exhibits
2023-12-14Entry into a material agreement · Other events · Financial statements and exhibits
2023-10-18Officer or director change · Amendments to charter or bylaws · Financial statements and exhibits
2023-08-29Officer or director change · Amendments to charter or bylaws · Financial statements and exhibits
2023-05-31Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…